Show the Working

Restrict Junk Food Advertising and Extend Soft Drinks Levy

Liberal Democrat · what the evidence says

An independent, source-checked look at Liberal Democrat’s policy “Restrict Junk Food Advertising and Extend Soft Drinks Levy” — what it would actually do across the things that affect your life. Every claim below quotes the source behind it. How this works.

Public finances & the next generation — Helps

minor · low confidence

Extending the soft drinks levy raises modest additional tax revenue and could reduce NHS costs over time, but independent analysts say the health impact is very small, so any long-term fiscal saving is likely limited. The advertising restrictions are regulatory and impose minimal direct cost to the Exchequer.

The evidence

Biggest unknown: How much tax revenue the levy extension actually raises and whether NHS cost savings materialise at sufficient scale to meaningfully shift the long-run debt path.

Our reading: This policy has two fiscal channels. First, the levy extension is a direct revenue measure — it taxes a new category of drinks, generating Exchequer receipts without new unfunded spending commitments. This unambiguously reduces near-term borrowing needs, however modestly. The extension is also expected to bring an additional 12% of soft drink litres into scope, so there is a real (if limited) revenue base. Second, both the levy and advertising restrictions could reduce NHS costs over the long run if they curb obesity and related diseases — the government projects £1 billion in health and economic benefits from the levy extension and £2 billion from the advertising ban. These are long-term and contingent. The IFS — a credible independent body — judges the levy extension's health impact 'extremely small', with only 0.3 kcal per person per day reduction, 60 times smaller than the original levy. If health benefits are that modest, the long-run NHS savings will be correspondingly minor. The advertising restrictions face their own dilution problems (1% of ad spend affected by some estimates), further compressing potential downstream fiscal gains. The advertising element is regulatory rather than fiscal: it imposes minimal direct cost on the Exchequer, so it does not worsen the debt path. On balance, the policy marginally improves O12: it raises some revenue without unfunded spending, and points in the right direction on NHS cost reduction, but the magnitude is small and the long-term health-driven savings are uncertain. This is not a transformative fiscal move.

Inequality & fair shares — Genuinely contested

n/a · low confidence

The evidence provided focuses on health outcomes and calorie reductions but does not address how the gains and costs of this policy are distributed across income groups. Without distributional data, it is not possible to determine whether the gap between rich and poor narrows or widens.

The evidence

Biggest unknown: Whether the soft drinks levy extension acts regressively (taking a higher share of income from poorer households) or progressively (delivering larger health benefits to disadvantaged groups who bear higher obesity burdens) — the provided evidence does not address this.

Our reading: O14 asks whether this policy narrows or widens the gap between the richest and the rest. The relevant question is: who pays the costs and who receives the benefits? For a consumption levy, costs fall on purchasers of the taxed products; for advertising restrictions, benefits accrue to children exposed to those ads. Neither of these distributional questions is addressed by any of the provided evidence units, which focus entirely on calorie reduction, obesity case counts, and health-system savings at population level. The IFS evidence (E28–E30) flags that the levy extension's aggregate health effect is very small ('small tweaks', 0.3 kcal/person/day), which further reduces the likelihood that any distributional effect — in either direction — would be detectable at scale. Without at least one evidence unit bearing on the income-distributional incidence of the levy or the socioeconomic gradient of who is exposed to the restricted advertising, no honest verdict on O14's direction can be returned. The verdict is therefore too-uncertain, driven by an absence of relevant distributional evidence rather than a genuine expert disagreement on a known parameter.

Cost of living — Hurts

minor · moderate confidence

Extending the soft drinks levy to more drinks will likely push up prices slightly on those products, hitting everyday shoppers — though the affected market is small and any long-run health savings could partially offset household costs. The IFS judges the broader health impact too small to materially change spending patterns.

The evidence

Biggest unknown: Whether manufacturers absorb the levy or pass it fully to consumers, and how far price increases land on lower-income households who spend a higher share of income on food and drink.

Our reading: For the cost-of-living fundamental, the key question is whether this policy raises prices on essentials or improves household affordability. The levy extension directly applies a financial charge to a wider range of drinks; to the extent manufacturers pass this on, consumers pay more for milk-based and juice-based beverages. Plain, unsweetened milk is exempt, so the poorest staples are not targeted, but flavoured milks and milkshakes — bought disproportionately by lower-income families — are in scope. The affected market is genuinely small: milk-based drinks are 174 million litres versus 4.4 billion for carbonated drinks, so the aggregate consumer cost increase is modest. The IFS finds the health impact 'extremely small' — roughly 0.3 kcal per person per day — which implies both that reformulation incentives are weak and that any compensating long-run health savings to household budgets will be negligible. Government projections of £1 billion in health benefits are contested and long-run; they do not offset near-term price rises for affected households. The advertising restrictions do not directly touch prices or incomes, so their O2 effect is negligible. On balance, the policy marginally worsens cost of living by raising prices on a small category of drinks, with the scale of harm being minor given the narrow scope. The direction is 'worsens' but the magnitude is genuinely minor, and confidence is moderate because pass-through rates are uncertain.

Healthcare — Mixed picture

minor · low confidence

This policy could modestly reduce childhood obesity and sugar-related disease over time, which would ease some pressure on the NHS — but major loopholes in the advertising ban and a very small projected impact from the levy extension mean real-world gains for healthcare access are likely limited. The biggest uncertainty is whether industry workarounds will neutralise the intended effect.

The evidence

Biggest unknown: Whether food companies shift spending to unregulated channels (social media, apps, outdoor) fast enough to cancel out the advertising restrictions, and whether the levy extension produces meaningful reductions in disease burden given IFS estimates of only 0.3 kcal per person per day.

Our reading: The policy operates on a long causal chain: restrict sugar marketing and consumption → reduce childhood obesity and sugar-related disease → reduce NHS demand → improve healthcare access for all. The evidence supports the direction of travel but raises serious questions about scale. On the advertising side, there is good mechanistic evidence that junk food advertising shapes children's eating habits and raises obesity risk (E4), and the government projects 20,000 fewer obesity cases per year (E2). However, the ban is substantially hollowed out: it covers only 1% of annual food advertising spend (E12), excludes out-of-home advertising (E9), permits brand advertising for HFSS-synonymous brands (E10–E11), and experts expect substantial ad-spend migration to unregulated channels (E14). The headline calorie-saving figure is therefore likely an overestimate of real-world effect. On the levy extension, the original SDIL is the strongest plank — it demonstrably reduced sugar content by ~50% (E19) and was associated with falls in childhood obesity and hospital admissions for tooth extractions (E21). That established mechanism lends credibility to extending the levy. But the IFS concludes the specific extension adds only 0.3 kcal per person per day — 60 times smaller than the original levy's effect (E29) — and calls it a 'small tweak' unlikely to shift obesity trends (E30). Milk-based drinks are a tiny fraction of total soft drink sales (E33), limiting scope. For O3 specifically, the NHS benefit pathway depends on material reductions in obesity and chronic disease burden. The original levy evidence is encouraging, but both extensions are substantially weaker than their headline billing. Some genuine benefit is plausible over the long term, but it cannot be characterised as more than minor, and low confidence is warranted given contested projections and the significant loopholes documented in the advertising restrictions.

Compare all parties on public finances & the next generation →Compare all parties on inequality & fair shares →Compare all parties on cost of living →Compare all parties on healthcare →Open this in the interactive comparison →← Show the Working home